跳至主要内容
临床试验/IRCT20180814040795N1
IRCT20180814040795N1招募中2 期

Evauating the effects of oral N-acetylcysteinas in comparing with pregabalin for pain managementinpatients with painful diabetic neuropathy.

Hamedan University of Medical Sciences0 个研究点目标入组 140 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 70 years(—)
性别
All

入选标准

  • Age 30 to 70 years old
  • History of DM2 at least one year ago
  • Hb A1C less than or equal to 9
  • Diabetic Neuropathy with NDS score greater than or equal to 6; VAS Score fore pain at least 4 and NSS score greater than or equal to 5.
  • Glomerular filteration rate more than 30cc/min

排除标准

  • Type 1 diabetes
  • Pregnancy or breast feeding
  • Diabetic foot ulcer
  • Neuropathy for reason other than diabetes
  • History of cerebrovascular disease and discopathy
  • Use other medications to relieve symptoms of neuropathy
  • Use of alcoholic drink or opioids

研究者

相似试验